Sage Therapeutics (SAGE) Soars 35.4%: Is Further Upside Left in the Stock?

Sage Therapeutics, Inc. (SAGE) shares ended the last trading session 35.4% higher at $9.07. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 2.8% loss over the past four weeks.The stock rallied after the company announced that Supernus Pharmaceuticals has agreed to acquire Sage Therapeutics through a tender offer of $8.50 per share in cash, totaling around $561 million. Additionally, shareholders will receive a non- ...